As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.
13 Analysts have issued a Fagron SA forecast:
13 Analysts have issued a Fagron SA forecast:
Jun '25 |
+/-
%
|
||
Revenue | 919 919 |
12%
12%
|
|
Gross Profit | 420 420 |
16%
16%
|
|
EBITDA | 184 184 |
15%
15%
|
EBIT (Operating Income) EBIT | 140 140 |
17%
17%
|
Net Profit | 86 86 |
10%
10%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Head office | Belgium |
Employees | 3,989 |
Website | fagron.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.